UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Korea still one step behind in protecting foreigners
Despite the national slogan to attract more foreign tourists, the governmen...
by Lee Han-soo
|
2017-11-27 17:50
라인
Seoul to get rid of plastic surgery ads in subways by 2022
The Seoul Metro said Monday it would get rid of plastic surgery advertiseme...
by Marian Chu
|
2017-11-27 17:28
라인
Green Cross, Feldan start joint tech development
Green Cross Labcell and Feldan Therapeutics, a Canadian biotechnology compa...
by Lee Han-soo
|
2017-11-27 16:59
라인
Hospital wins patent in VR treatment for cognitive disorders
A local hospital is drawing attention by winning a patent in cognitive reha...
by Nam Doo-hyun
|
2017-11-27 16:05
라인
Ministry renews ‘innovative’ certification for 3 pharmaceuticals
The Ministry of Health and Welfare said it has recertified three pharmaceut...
by Marian Chu
|
2017-11-27 14:59
라인
Foreigners dump Medytox, Hugel; buy Celltrion, ViroMed
On Korea’s secondary stock market, foreign investors net bought the shares ...
by Nam Doo-hyun
|
2017-11-27 13:13
라인
AbbVie to present phase 3 study on investigational leukemia drug
AbbVie said Thursday that the American Society of Hematology (ASH) accepted...
by Marian Chu
|
2017-11-27 12:14
라인
KHMC to host symposium on rectal cancer
Kyung Hee University Medical Center (KHMC) said Monday that it would host t...
by Constance Williams
|
2017-11-27 12:07
라인
Celltrion joins local drugmakers to tap US generic market
Korea’s generic drug manufacturers are entering the U.S. pharmaceutical mar...
by So Jae-hyeon
|
2017-11-27 12:04
라인
Biogen Korea taps new CEO
Biogen Korea, the Korean branch of the American multinational biotech Bioge...
by Marian Chu
|
2017-11-27 11:57
라인
Samsung unveils next-generation radiology tech in US
Samsung Electronics and Samsung Medison said they have developed various ne...
by Lee Han-soo
|
2017-11-27 11:44
라인
SK Chemicals, Pfizer locked in patent dispute over pneumonia vaccine
Results from a patent dispute between SK Chemicals and Pfizer will be relea...
by Marian Chu
|
2017-11-24 16:23
라인
Clinical trials on CAR-T cell therapies surge in two years
The number of clinical trials on CAR-T (chimeric antigen receptor T-cell) t...
by Nam Doo-hyun
|
2017-11-24 15:53
라인
Method developed to minimize damage on sural artery perforator flap surgery
A Seoul National University Hospital research team has developed a method t...
by Constance Williams
|
2017-11-24 15:11
라인
Trauma surgeon Lee’s appeals push government to act
The Ministry of Health and Welfare said it would come up with measures to i...
by Kwak Sung-sun
|
2017-11-24 14:59
라인
Government pushes ‘automatic claims’ for medical indemnity
The government said it would push to help Koreans automatically file their ...
by Kwak Sung-sun
|
2017-11-24 14:18
라인
CGBIO’s bone graft selected as next-generational product
CGBIO said Friday its bone graft infused with a protein called rhBMP-2, Nov...
by Marian Chu
|
2017-11-24 13:27
라인
Otezla, oral treatment for psoriasis, lands in Korea
The Ministry of Food and Drug Safety on Monday approved the local sales of ...
by Lee Hye-seon
|
2017-11-24 11:53
라인
JW Shinyak to sell J&J’s hair loss treatment in Korea
Officials from JW Shinyak and Johnson & Johnson pose after signing the excl...
by Lee Han-soo
|
2017-11-24 11:43
라인
Kolon okayed for clinical trial to expand treatment for Invossa-K injection
The Ministry of Food and Drug Safety (MFDS) has approved Kolon Life Science...
by Lee Han-soo
|
2017-11-23 15:53
-
이전
261
262
263
264
265
266
267
268
269
270
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top